Pediatric (Non-CNS) Tumors
This chapter will discuss management of pediatric tumors including Wilms’ tumor, neuroblastoma, rhabdomyosarcoma, Ewing’s sarcoma, pediatric Hodgkin’s lymphoma, and retinoblastoma.
KeywordsWilms’ tumor Neuroblastoma Rhabdomyosarcoma Ewing’s sarcoma Pediatric Hodgkin’s lymphoma Retinoblastoma
We thank Stuart Y. Tsuji MD, PhD, and Linda W. Chan, MD, for their work on the prior edition of this chapter.
- Park JR, Kreissman SG, London WB, et al. A phase 3 randomized clinical trial of tandem myeloablative autologous stem cell transplant using peripheral blood stem cell as consolidation therapy for high-risk neuroblastoma: a children’s oncology group study. 2016 ASCO Annual Meeting. Abstract LBA3. 2016.Google Scholar
- Peifer M, Hertwig F, Roeis F, et al. Telomerase activation by genomic rearrangements in high-risk neuroblastoma. Nature. 2015;526(7575):700–4.Google Scholar
- Arndt CA, Stoner JA, Hawkins DS, et al. Vincristine, actinomycin, and cyclophosphamide compared with vincristine, actinomycin, and cyclophosphamide alternating with vincristine, topotecan, and cyclophosphamide for intermediate-risk rhabdomyosarcoma: children’s oncology group study D9803. J Clin Oncol. 2009;27(31):5182–8.CrossRefGoogle Scholar
Pediatric Hodgkin’s Lymphoma
- Friedman DL, Chen L, Wolden S, et al. Dose-intensive response-based chemotherapy and radiation therapy for children and adolescents with newly diagnosed intermediate-risk Hodgkin lymphoma: A report from Children’s Oncology Group Study AHOD0031. J Clin Oncol. 2014;32(32):3651–8.CrossRefGoogle Scholar